617 related articles for article (PubMed ID: 27798020)
1. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
[TBL] [Abstract][Full Text] [Related]
2. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.
Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC
BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209
[TBL] [Abstract][Full Text] [Related]
3. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.
Fitzgerald DB; Sidhu C; Budgeon C; Tan AL; Read CA; Kwan BCH; Smith NA; Fysh ET; Muruganandan S; Saghaie T; Shrestha R; Badiei A; Nguyen P; Burke A; Goddard J; Windsor M; McDonald J; Wright G; Czarnecka K; Sivakumar P; Yasufuku K; Feller-Kopman DJ; Maskell NA; Murray K; Lee YCG
Trials; 2022 Jun; 23(1):530. PubMed ID: 35761341
[TBL] [Abstract][Full Text] [Related]
4. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
Davies HE; Mishra EK; Kahan BC; Wrightson JM; Stanton AE; Guhan A; Davies CW; Grayez J; Harrison R; Prasad A; Crosthwaite N; Lee YC; Davies RJ; Miller RF; Rahman NM
JAMA; 2012 Jun; 307(22):2383-9. PubMed ID: 22610520
[TBL] [Abstract][Full Text] [Related]
5. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
[TBL] [Abstract][Full Text] [Related]
6. Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis.
Fysh ET; Thomas R; Read CA; Kwan BC; Yap E; Horwood FC; Lee P; Piccolo F; Shrestha R; Garske LA; Lam DC; Rosenstengel A; Bint M; Murray K; Smith NA; Lee YC
BMJ Open; 2014 Nov; 4(11):e006757. PubMed ID: 25377015
[TBL] [Abstract][Full Text] [Related]
7. Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.
Bhatnagar R; Luengo-Fernandez R; Kahan BC; Rahman NM; Miller RF; Maskell NA
Health Technol Assess; 2020 Jun; 24(26):1-90. PubMed ID: 32525474
[TBL] [Abstract][Full Text] [Related]
8. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial.
Muruganandan S; Azzopardi M; Fitzgerald DB; Shrestha R; Kwan BCH; Lam DCL; De Chaneet CC; Rashid Ali MRS; Yap E; Tobin CL; Garske LA; Nguyen PT; Stanley C; Popowicz ND; Kosky C; Thomas R; Read CA; Budgeon CA; Feller-Kopman D; Maskell NA; Murray K; Lee YCG
Lancet Respir Med; 2018 Sep; 6(9):671-680. PubMed ID: 30037711
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial.
Bhatnagar R; Laskawiec-Szkonter M; Piotrowska HE; Kahan BC; Hooper CE; Davies HE; Harvey JE; Miller RF; Rahman NM; Maskell NA
BMJ Open; 2014 Nov; 4(11):e007045. PubMed ID: 25428632
[TBL] [Abstract][Full Text] [Related]
10. Australasian Malignant PLeural Effusion (AMPLE)-4 trial: study protocol for a multi-centre randomised trial of topical antibiotics prophylaxis for infections of indwelling pleural catheters.
Lau EPM; Ing M; Vekaria S; Tan AL; Charlesworth C; Fysh E; Shrestha R; Yap ELC; Smith NA; Kwan BCH; Saghaie T; Roy B; Goddard J; Muruganandan S; Badiei A; Nguyen P; Hamid MFA; George V; Fitzgerald D; Maskell N; Feller-Kopman D; Murray K; Chakera A; Lee YCG
Trials; 2024 Apr; 25(1):249. PubMed ID: 38594766
[TBL] [Abstract][Full Text] [Related]
11. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
Fysh ETH; Waterer GW; Kendall PA; Bremner PR; Dina S; Geelhoed E; McCarney K; Morey S; Millward M; Musk AWB; Lee YCG
Chest; 2012 Aug; 142(2):394-400. PubMed ID: 22406960
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
[TBL] [Abstract][Full Text] [Related]
13. The randomised thoracoscopic talc poudrage+indwelling pleural catheters versus thoracoscopic talc poudrage only in malignant pleural effusion trial (TACTIC): study protocol for a randomised controlled trial.
Dipper A; Sundaralingam A; Hedley E; Tucker E; White P; Bhatnagar R; Moore A; Dobson M; Luengo-Fernandez R; Mills J; Sowden S; Harvey JE; Dobson L; Miller RF; Munavvar M; Rahman N; Maskell N
BMJ Open Respir Res; 2023 May; 10(1):. PubMed ID: 37253535
[TBL] [Abstract][Full Text] [Related]
14. The impact of outpatient
Sivakumar P; Fitzgerald DB; Ip H; Rao D; West A; Noorzad F; Wallace D; Haris M; Prudon B; Hettiarachchi G; Jayaram D; Goldring J; Maskell N; Holme J; Sharma N; Ismail I; Kadwani O; Simpson S; Read CA; Sun X; Douiri A; Lee YCG; Ahmed L
Eur Respir J; 2024 Feb; 63(2):. PubMed ID: 37996243
[TBL] [Abstract][Full Text] [Related]
15. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis.
Yeung M; Loh EW; Tiong TY; Tam KW
Clin Exp Metastasis; 2020 Aug; 37(4):541-549. PubMed ID: 32524317
[TBL] [Abstract][Full Text] [Related]
16. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG
JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255
[TBL] [Abstract][Full Text] [Related]
17. Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion.
Penz ED; Mishra EK; Davies HE; Manns BJ; Miller RF; Rahman NM
Chest; 2014 Oct; 146(4):991-1000. PubMed ID: 24832000
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial.
Bhatnagar R; Kahan BC; Morley AJ; Keenan EK; Miller RF; Rahman NM; Maskell NA
Trials; 2015 Feb; 16():48. PubMed ID: 25880969
[TBL] [Abstract][Full Text] [Related]
19. Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion.
Bhatnagar R; Keenan EK; Morley AJ; Kahan BC; Stanton AE; Haris M; Harrison RN; Mustafa RA; Bishop LJ; Ahmed L; West A; Holme J; Evison M; Munavvar M; Sivasothy P; Herre J; Cooper D; Roberts M; Guhan A; Hooper C; Walters J; Saba TS; Chakrabarti B; Gunatilake S; Psallidas I; Walker SP; Bibby AC; Smith S; Stadon LJ; Zahan-Evans NJ; Lee YCG; Harvey JE; Rahman NM; Miller RF; Maskell NA
N Engl J Med; 2018 Apr; 378(14):1313-1322. PubMed ID: 29617585
[TBL] [Abstract][Full Text] [Related]
20. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
